Research Topics
Species | LARS FREDRIK JARSKOGSummaryAffiliation: University of North Carolina Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Schizophrenia: new pathological insights and therapiesL Fredrik Jarskog
Department of Psychiatry, Schizophrenia Research Center, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA
Annu Rev Med 58:49-61. 2007..This review provides an update on developments in research on the neuropathology of schizophrenia and discusses recent advances in antipsychotic treatment and the potential impact on long-term outcomes...
Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activationL Fredrik Jarskog
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599 7160, USA
Am J Psychiatry 161:109-15. 2004..It was hypothesized that the Bax/Bcl-2 ratio, but not caspase-3, would be high in the temporal cortex of patients with chronic schizophrenia...
Apoptotic mechanisms in the pathophysiology of schizophreniaL Fredrik Jarskog
Department of Psychiatry, Schizophrenia Research Center, University of North Carolina Chapel Hill, CB 7160, Chapel Hill, NC 27599 7160, USA
Prog Neuropsychopharmacol Biol Psychiatry 29:846-58. 2005..Although the exact role of apoptosis in schizophrenia remains uncertain, the potential involvement of non-lethal localized apoptosis is intriguing, especially in earlier stages of the illness...
Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychoticsL Fredrik Jarskog
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7160, USA
Neuropsychopharmacology 32:95-102. 2007..Although the association between antipsychotic treatment and increased pro-apoptotic caspase-3 is intriguing, further study is needed to understand its potential effects...
Apoptosis in schizophrenia: pathophysiologic and therapeutic considerationsL Fredrik Jarskog
Department of Psychiatry, Schizophrenia Research Center, University of North Carolina, Chapel Hill 27599 7160, USA
Curr Opin Psychiatry 19:307-12. 2006..This paper will review studies of apoptotic regulatory proteins, DNA fragmentation, and gene microarrays to highlight the potential role of apoptosis in the pathophysiology and treatment of schizophrenia...
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorderDiana O Perkins
Department of Psychiatry, University of North Carolina at Chapel Hill, CB 7160, Chapel Hill, NC 27599, USA
Genome Biol 8:R27. 2007..They have been implicated in the etiology of a variety of complex diseases, including Tourette's syndrome, Fragile x syndrome, and several types of cancer...
Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the ratJohn H Gilmore
Department of Psychiatry, CB 7160, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7160, USA
J Neuroimmunol 138:49-55. 2003..Abnormal expression of neurotrophic factors represents a potential mechanism through which maternal infection increases risk for neurodevelopmental disorders...
Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the ratJohn H Gilmore
UNC Schizophrenia Research Center, Department of Psychiatry, CB 7160, University of North Carolina, Chapel Hill, NC 27599 7160, USA
J Neuroimmunol 159:106-12. 2005..Changes in TNFalpha, BDNF, and NGF after maternal exposure to poly I:C represent a potential mechanism through which maternal infection increases risk for neurodevelopmental disorders...
Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortexMaile A Henson
Curriculum in Neurobiology, University of North Carolina, Chapel Hill, NC 27705, USA
Cereb Cortex 18:2560-73. 2008..These data provide insights into NMDAR functions in the developing CNS and will contribute to designing pharmacotherapies for neurological disorders...
Neuroprotection in schizophreniaL Fredrik Jarskog
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, USA
J Clin Psychiatry 67:e09. 2006....
Regulation of complexin 1 and complexin 2 in the developing human prefrontal cortexKayvon Salimi
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Synapse 62:273-82. 2008....
Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depressionLeisa A Glantz
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Schizophr Res 118:292-9. 2010..Changes in the Par-4/D2DR signaling pathway represent a novel mechanism that may link apoptotic and dopamine signaling pathways in major depression and schizophrenia...
Apoptotic mechanisms and the synaptic pathology of schizophreniaLeisa A Glantz
Department of Psychiatry, University of North Carolina-Chapel Hill, CB# 7160, Chapel Hill, NC 27599-7160, USA
Schizophr Res 81:47-63. 2006..This paper will review converging lines of data that implicate synaptic deficits in the pathophysiology of schizophrenia and propose an underlying role for apoptotic dysregulation...
Secretin in a patient with treatment-resistant schizophrenia and prominent autistic featuresSayed S Alamy
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7160, USA
Schizophr Res 66:183-6. 2004..The case illustrates the potential role of secretin as a novel adjunctive treatment strategy in schizophrenic patients with autistic features...
Deficits in adult prefrontal cortex neurons and behavior following early post-natal NMDA antagonist treatmentLeon G Coleman
Curriculum in Neurobiology, Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7178, United States
Pharmacol Biochem Behav 93:322-30. 2009..These findings indicate that early brain insults affecting glutamatergic neurotransmission lead to persistent brain pathology that could contribute to impulsivity and cognitive dysfunction...
Antipsychotic drugs for first-episode schizophrenia: a comparative reviewKayvon Salimi
Department of Psychiatry, University of North Carolina at Chapel Hill, USA
CNS Drugs 23:837-55. 2009..However, metabolic concerns associated with many atypical agents along with limited benefits in cognition and negative symptom domains highlight the persistent therapeutic needs of these patients...
Research Grants
- Bcl-2 Family Protein and Apoptosis in SchizophreniaLARS JARSKOG; Fiscal Year: 2005..Stereological neuronal cell counting and measurement of somal size will also be assessed. Finally, young adult rats will receive typical and atypical antipsychotics to assess their effect on the apoptotic regulatory proteins. ..
